RP Bio Inc. (KOSDAQ:314140)
South Korea · Delayed Price · Currency is KRW 5,760.00
+150.00 (2.67%)
At close: May 29, 2026
RP Bio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 5,603 | 4,682 | -907.12 | 5,437 | 4,316 | 3,813 |
Depreciation & Amortization | 6,310 | 6,412 | 6,818 | 6,048 | 5,403 | 5,203 |
Loss (Gain) From Sale of Assets | 178.59 | 178.59 | 9.24 | - | -150.06 | 4.31 |
Loss (Gain) From Sale of Investments | -9.22 | -1.59 | - | - | - | - |
Stock-Based Compensation | - | - | - | -5.77 | 10.54 | 14.57 |
Provision & Write-off of Bad Debts | 50.3 | 294.03 | 2.7 | 0.09 | -26.95 | -36.16 |
Other Operating Activities | 4,505 | 3,393 | 1,794 | 2,106 | 7,149 | 3,781 |
Change in Accounts Receivable | 3,645 | -1,135 | 2,334 | 777.83 | -1,651 | -4,355 |
Change in Inventory | -4,261 | -1,267 | 10,245 | 3,755 | -16,021 | -6,180 |
Change in Accounts Payable | 493.2 | 2,098 | -3,406 | -9,044 | 5,252 | 9,117 |
Change in Other Net Operating Assets | -53.34 | -2,179 | -3,366 | 1,505 | -3,125 | -1,902 |
Operating Cash Flow | 16,462 | 12,476 | 13,524 | 10,580 | 1,155 | 9,459 |
Operating Cash Flow Growth | 1.63% | -7.75% | 27.82% | 816.03% | -87.79% | 46.55% |
Capital Expenditures | -3,816 | -5,200 | -5,853 | -11,123 | -5,147 | -7,246 |
Sale of Property, Plant & Equipment | 19.58 | 19.58 | 14.38 | 69.73 | 165.55 | - |
Sale (Purchase) of Intangibles | -371.37 | -411.27 | -157.78 | -41.02 | -132.18 | -24.59 |
Investment in Securities | 5,574 | -100 | 4,405 | -7,803 | -7.2 | 308.64 |
Other Investing Activities | -1,676 | -1,675 | 390.45 | -6.67 | -218.69 | -204.13 |
Investing Cash Flow | 332.11 | -7,066 | -1,501 | -18,264 | -5,939 | -7,166 |
Short-Term Debt Issued | - | 16,000 | 21,000 | - | 14,500 | 23,235 |
Total Debt Issued | 16,000 | 16,000 | 21,000 | - | 14,500 | 23,235 |
Short-Term Debt Repaid | - | -25,000 | -21,000 | -5,000 | -14,500 | -26,104 |
Long-Term Debt Repaid | - | -688.6 | -665.09 | -919.92 | -453 | -522.83 |
Total Debt Repaid | -21,646 | -25,689 | -21,665 | -5,920 | -14,953 | -26,627 |
Net Debt Issued (Repaid) | -5,646 | -9,689 | -665.09 | -5,920 | -453 | -3,392 |
Issuance of Common Stock | - | - | - | - | 16,287 | - |
Dividends Paid | - | - | -432.49 | - | - | - |
Other Financing Activities | 500 | - | - | -3.79 | -502.46 | - |
Financing Cash Flow | -5,146 | -9,689 | -1,098 | -5,924 | 15,332 | -3,392 |
Foreign Exchange Rate Adjustments | -6.61 | -6.61 | - | - | - | - |
Miscellaneous Cash Flow Adjustments | 0 | - | -0 | - | - | -0 |
Net Cash Flow | 11,641 | -4,285 | 10,925 | -13,608 | 10,547 | -1,099 |
Free Cash Flow | 12,645 | 7,276 | 7,670 | -543.31 | -3,992 | 2,213 |
Free Cash Flow Growth | 37.82% | -5.14% | - | - | - | - |
Free Cash Flow Margin | 9.21% | 5.34% | 6.19% | -0.36% | -2.89% | 1.93% |
Free Cash Flow Per Share | 1461.47 | 841.15 | 887.85 | -58.16 | -560.54 | 336.69 |
Cash Interest Paid | 705.34 | 831.79 | 1,316 | 1,816 | 989.75 | 638.38 |
Cash Income Tax Paid | 506.47 | 394.19 | 439.62 | 992.04 | 246.9 | 122.34 |
Levered Free Cash Flow | 7,787 | 5,302 | 6,556 | -6,112 | -3,592 | -1,246 |
Unlevered Free Cash Flow | 8,227 | 5,820 | 7,338 | -4,990 | -2,852 | -633.95 |
Change in Working Capital | -175.58 | -2,482 | 5,807 | -3,006 | -15,546 | -3,321 |